thiazoles has been researched along with pyrazinamide in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashtekar, DR; Fernandes, F; Khadse, BG; Shirodkar, MV | 1 |
| Furitsu, H; Iga, T; Kotaki, H; Sawada, Y; Yamada, H | 1 |
| SPARKUHL, K; WEBB, WR | 1 |
| Cui, Z; Hu, Z; Huang, X; Lu, J; Wang, J; Zheng, R | 1 |
| Adelakun, A; Bhatnagar, V; Chen, Q; Emadi, A; Farshidpour, M; Holtzman, N; Kendall, T; Stevenson, B | 1 |
5 other study(ies) available for thiazoles and pyrazinamide
| Article | Year |
|---|---|
A rapid method for the evaluation of new antituberculous agents.
Topics: Antitubercular Agents; Carbon Dioxide; Ethambutol; Guanidines; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Scintillation Counting; Streptomycin; Succinimides; Thiazoles; Time Factors | 1987 |
Mechanism of the uricosuric action of E3040, a drug used to treat inflammatory bowel disease II: study using DBA/2N mice.
Topics: Animals; Benzothiazoles; Gastrointestinal Agents; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred DBA; Pyrazinamide; Pyridines; Thiazoles; Uric Acid; Uricosuric Agents | 1999 |
Pulmonary resection for tuberculosis under protection of viomycin, promizole and pyrazinamide.
Topics: Niacin; Nicotinic Acids; Pneumonectomy; Pyrazinamide; Sulfathiazole; Sulfathiazoles; Thiazoles; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1958 |
Evaluation of methods for testing the susceptibility of clinical Mycobacterium tuberculosis isolates to pyrazinamide.
Topics: Amidohydrolases; Antitubercular Agents; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Pyrazinamide; Tetrazolium Salts; Thiazoles; Xanthenes | 2013 |
Diseases at the crossroads: chronic myelogenous leukemia and tuberculosis.
Topics: Adult; Antitubercular Agents; Dasatinib; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Moxifloxacin; Peritonitis, Tuberculous; Protein Kinase Inhibitors; Pyrazinamide; Pyrimidines; Thiazoles | 2015 |